PX1 Research supplies high-purity SS-31 (Elamipretide) synthesized in domestic, GMP-compliant facilities for advanced cellular and mitochondrial research. Every lot undergoes rigorous high-performance liquid chromatography, mass spectrometry analysis, and endotoxin testing at an independent ISO 17025 accredited laboratory to guarantee absolute identity and consistency for in vitro and preclinical experimental models.
PX1 Research supplies high-purity SS-31 (Elamipretide) synthesized in domestic, GMP-compliant facilities for advanced cellular and mitochondrial research. Every lot undergoes rigorous high-performance liquid chromatography, mass spectrometry analysis, and endotoxin testing at an independent ISO 17025 accredited laboratory to guarantee absolute identity and consistency for in vitro and preclinical experimental models.
SS-31, also designated in scientific literature as Elamipretide or Szeto-Schiller-31, is a synthetic tetrapeptide structurally designed to selectively target and concentrate within the inner mitochondrial membrane (IMM). With the chemical structure D-Arg-Dmt-Lys-Phe-NH2 (where Dmt represents 2',6'-dimethyltyrosine), this cationic, aromatic peptide possesses unique biochemical characteristics that allow it to cross cell membranes independent of membrane potential.
In biomedical research, SS-31 is classified primarily as a mitochondrial-targeted therapeutic candidate. Preclinical investigations focus on its ability to interact specifically with cardiolipin, an essential phospholipid localized exclusively to the inner mitochondrial membrane. Because mitochondrial dysfunction underpins a broad array of cellular pathologies, researchers utilize research-grade peptides like SS-31 to probe mechanisms related to oxidative phosphorylation efficiency, reactive oxygen species (ROS) attenuation, and structural cristae maintenance.
When conducting sensitive biochemical assays or long-term animal studies, raw material consistency and purity are paramount. Sourcing SS-31 made in USA provides research institutions and laboratory directors with strict supply chain oversight, transparent manufacturing protocols, and compliance with high-tier quality management frameworks. Domestic synthesis eliminates the common pitfalls of international peptide procurement, such as lot-to-lot batch variance, residual trifluoroacetic acid (TFA) contamination, and chemical degradation caused by prolonged, unmonitored transoceanic transit.
PX1 Research prioritizes domestic manufacturing to maintain rigid quality control over every synthesis run. Our US-based production facilities operate under cGMP guidelines, employing solid-phase peptide synthesis (SPPS) methods optimized for high-yield purity and structural accuracy. For investigators seeking reliable experimental outcomes, purchasing the SS-31 product page direct from a domestic supplier ensures that reagents meet non-negotiable chemical standards before arrival at the laboratory bench.
The primary mechanism of SS-31 revolves around its electrostatic and hydrophobic affinity for cardiolipin. Cardiolipin is a dimeric phospholipid critical for maintaining inner mitochondrial membrane curvature and stabilizing electron transport chain (ETC) supercomplexes (respirasomes). In vitro models demonstrate that during cellular stress or pathologically elevated oxidative conditions, cardiolipin undergoes peroxidation, destabilizing the respirasome architecture and increasing electron leakage.
Preclinical data indicate that SS-31 penetrates the outer mitochondrial membrane and transiently binds cardiolipin via hydrogen bonding and hydrophobic interactions with its dimethyltyrosine residue. This binding prevents cardiolipin from converting cytochrome c into a peroxidase, thereby maintaining electron transfer along Complexes I through IV. As a result, experimental models demonstrate preserved adenosine triphosphate (ATP) synthesis, reduced mitochondrial ROS production, and inhibition of the permeability transition pore (mPTP) opening, which suppresses pro-apoptotic signaling pathways.
To ensure that laboratory evaluations yield unambiguous data, PX1 Research Subjects every batch of SS-31 to comprehensive analytical testing. Purity verification is performed using High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS). HPLC analysis confirms overall peptide purity, ensuring that synthetic impurities, truncated sequences, or protecting-group side products are minimized below strict thresholds (typically ≥98.0% purity).
Electrospray Ionization Mass Spectrometry (ESI-MS) validates the exact molecular weight (639.8 g/mol) and identity of the peptide sequence. Crucially, because SS-31 is frequently employed in sensitive cell culture lines and in vivo animal models, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing for bacterial endotoxins. Testing is performed through an independent, ISO 17025 accredited laboratory, with full Certificates of Analysis (COA) provided for total institutional transparency.
In mitochondrial biology and cellular aging research, investigators frequently evaluate multiple targets within the bioenergetic framework. Comparing SS-31 against other compounds in the mitochondrial target space illustrates its specific functional niche:
While SS-31 acts via direct physical interaction with cardiolipin in the inner mitochondrial membrane, peptides such as MOTS-c function as mitochondrial-derived signaling factors that translocate to the nucleus during metabolic stress to regulate genomic gene expression. Concurrently, compounds like Humanin act primarily through cell-surface and intracellular receptors to exert cytoprotective and anti-apoptotic signaling. In contrast to broader cytoprotective agents like BPC-157, which influence angiogenic and extracellular matrix repair pathways, SS-31 remains specifically focused on preserving mitochondrial membrane structure and respirasome bioenergetics. Understanding these distinct pathways allows researchers to design highly focused single-variable or comparative experimental protocols.
Research literature documents the utilization of SS-31 across a diverse set of preclinical model systems. In neurobiology studies, in vitro neuronal cell cultures exposed to neurotoxic stressors show preserved mitochondrial membrane potential and decreased apoptosis when pretreated with SS-31. Rodent models of acute kidney injury (AKI) and renal ischemia-reperfusion demonstrate that administration of research-grade SS-31 protects microvascular integrity and reduces tubular cell necrosis.
Furthermore, investigators studying cardiovascular energetics utilize SS-31 in isolated cardiomyocyte preparations and rodent models of heart failure. These studies indicate that stabilization of cardiolipin by SS-31 improves left ventricular function, reduces myocardial fibrosis, and restores state 3 mitochondrial respiration. Researchers exploring general tissue recovery and metabolic resilience frequently examine peptides for cellular research to establish baseline parameters across various organ systems.
Proper handling and storage protocols are critical to maintain the chemical stability and biological activity of lyophilized SS-31. The product is supplied as a sterile, lyophilized cake or powder and must be kept at -20°C or -80°C for long-term storage prior to reconstitution.
For laboratory reconstitution, researchers should utilize sterile, unpreserved laboratory-grade water or phosphate-buffered saline (PBS), depending on the specific downstream application. A step-by-step laboratory workflow includes:
1. Equilibrate the vial to room temperature prior to reconstitution to minimize moisture condensation. 2. Reconstitute under a laminar flow hood using sterile technique, introducing solvent gently along the inner glass wall of the vial. 3. Swirl gently without vigorous agitation to avoid protein foaming or physical shear stress. 4. Aliquot reconstituted solutions into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles. 5. Store reconstituted liquid aliquots at -20°C for up to 30 days, or at 4°C for immediate short-term use within 24–48 hours.
Academic laboratories, biotechnology enterprises, and contract research organizations (CROs) require dependable supply continuity and rigorous quality documentation. PX1 Research supports large-scale experimental designs by offering structured procurement options via wholesale laboratory accounts. Direct access to manufacturing lots ensures that multi-phase or longitudinal studies utilize peptides from the same production batch, eliminating variable controls across testing blocks.
In addition to batch consistency, PX1 offers custom synthesis options, specialized vial sizes, and bulk packaging for high-throughput screening platforms. Institutions interested in cross-referencing growth factor signaling or tissue regeneration markers can also integrate complementary compounds such as CJC-1295 into broader research projects through our centralized institutional supply channel.
To ensure that temperature-sensitive peptides maintain their chemical integrity during transit, PX1 Research operates state-of-the-art fulfillment facilities situated in California and Arizona. Orders received Monday through Friday are processed and shipped same-day, utilizing insulated, temperature-controlled packaging when required.
By maintaining strict oversight from US-based synthesis to final domestic shipping, PX1 eliminates international customs delays and cold-chain breakdowns. Researchers can rely on rapid delivery times, comprehensive analytical validation, and dedicated customer support designed specifically for laboratory professionals.
What is SS-31 and what is its primary molecular target in research?
SS-31 (Elamipretide) is a synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) designed to target the inner mitochondrial membrane. Its primary molecular target is cardiolipin, a unique phospholipid required for maintaining mitochondrial cristae structure and electron transport chain supercomplex efficiency.
Why is domestic US synthesis important for SS-31 research peptides?
Domestic synthesis in US-based GMP-compliant facilities guarantees strict quality control, predictable batch consistency, low TFA levels, and protection against degradation caused by extended international shipping transit times.
How does PX1 Research verify the purity and identity of SS-31?
Every lot of SS-31 undergoes high-performance liquid chromatography (HPLC) to verify chemical purity (≥98%), mass spectrometry (ESI-MS) to confirm molecular identity, and LAL assays to ensure endotoxin levels meet strict laboratory standards (<0.1 EU/mg). Testing is performed by an independent ISO 17025 accredited laboratory.
What endotoxin standards apply to PX1 SS-31 lots?
PX1 Research requires all SS-31 batches to undergo Limulus Amebocyte Lysate (LAL) testing, verifying endotoxin levels remain below 0.1 EU/mg. This ensures suitability for sensitive cell culture and animal models.
How should lyophilized SS-31 be stored upon arrival?
Lyophilized SS-31 should be stored at -20°C or -80°C in a desiccated environment away from direct light. Under these conditions, the peptide remains stable for up to 24 months.
What solvents are recommended for reconstituting SS-31 in a lab setting?
Reconstitution should be performed using sterile laboratory-grade water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of your specific in vitro or in vivo experimental assay.
How does SS-31 differ mechanistically from MOTS-c?
SS-31 acts directly on the inner mitochondrial membrane by binding cardiolipin to preserve cristae structure and ETC function. MOTS-c is a mitochondrial-derived peptide that functions primarily as a nuclear signaling molecule to regulate metabolic gene expression.
Is SS-31 approved for human consumption or therapeutic use?
No. SS-31 supplied by PX1 Research is strictly a research chemical intended solely for laboratory, in vitro, and preclinical research applications. It is not for human or animal consumption, medical treatment, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.